Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer

Purpose Weekly dose-dense paclitaxel (PTX) in combination with carboplatin (CBDCA) every 3 weeks (ddTC therapy) is a standard treatment for patients with advanced ovarian cancer. However, there is no detailed analysis of the feasibility of ddTC therapy in elderly patients with ovarian cancer. Method...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer chemotherapy and pharmacology 2016-10, Vol.78 (4), p.745-752
Hauptverfasser:	Bun, Seiko, Yunokawa, Mayu, Ebata, Takahiro, Shimomura, Akihiko, Shimoi, Tatsunori, Kodaira, Makoto, Yonemori, Kan, Shimizu, Chikako, Fujiwara, Yasuhiro, Kato, Tomoyasu, Makino, Yoshinori, Hayashi, Yoshikazu, Tamura, Kenji
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Aging Antineoplastic Agents - administration & dosage Antineoplastic Agents, Phytogenic - administration & dosage Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Research Carboplatin - administration & dosage Disease-Free Survival Drug Administration Schedule Fallopian Tube Neoplasms - drug therapy Feasibility Studies Female Humans Male Medicine Medicine & Public Health Middle Aged Oncology Original Article Ovarian Neoplasms - drug therapy Paclitaxel - administration & dosage Peritoneal Neoplasms - drug therapy Pharmacology/Toxicology Prognosis Retrospective Studies Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!